FIELD: chemistry, pharmaceutics.
SUBSTANCE: invention relates to novel chemical composition from group quaternary ammonium salts of succinic acid, namely, 1-deoxy-1-N-methyl ammonium-D-glucitole succinate (meglumine succinate) 
.
EFFECT: obtaining chemical composition which acquires ability to impact on complex of pathological changes accompanying sugar diabetes.
4 cl, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT SHOWING ANTIAGGREGATION ACTIVITY | 1991 |
|
RU2061481C1 |
| HAEMORHEOLOGIC AGENT CAPABLE OF REDUCING INSULING RESISTANCE AND RESTORING BODY TOLERANCE TO GLUCOSE AND PHARMACEUTICAL COMPOSITION BASED ON SAID AGENT | 2007 |
|
RU2386634C2 |
| PHARMACEUTICAL COMBINATION POSSESSING ANTIAGGREGANT AND LIPID-REGULATING ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2461379C2 |
| USING PREPARATION "REAMBIRIN-1.5% FOR INFUSION" AS AGENT FOR DECREASING BLOOD (PLASMA) VISCOSITY | 2004 |
|
RU2266110C1 |
| METHOD OF SYNTHESIS OF 1-ARYL-2-ARYLHYDROXYETHANE DERIVATIVES | 1990 |
|
RU2042659C1 |
| COMBINATION POSSESSING ANTIAGGREGANT, LIPID-REGULATING AND GASTROPROTECTIVE ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2453314C1 |
| DICALCIUM SALT OF N-(3-HYDROXYBENZOYL)TAURINE, HAVING ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY IN COMBINATION WITH CEREBROPROTECTIVE ACTION | 2019 |
|
RU2730835C1 |
| METHOD OF TREATING DIABETES IN MAMMALS AND INTRANASAL PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES IN MAMMALS | 2009 |
|
RU2403909C1 |
| 1-(3-MORPHOLINOPROPYL)-2-PHENYLIMIDAZO[1,2-a]-BENZIMIDAZOLE DIHYDROCHLORIDE, HAVING PURINE P2Y-RECEPTOR ANTAGONIST PROPERTIES, ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2008 |
|
RU2391345C2 |
| DIPOTASSIUM SALT OF N-(4-HYDROXYBENZOYL) TAURINE, HAVING ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2019 |
|
RU2731106C1 |
